Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. AI -Enhanced Zinc Finger Proteins May Reduce Immune Risks…

AI Risks June 05, 2025 · Genetic Engineering and Biotechnology News

AI -Enhanced Zinc Finger Proteins May Reduce Immune Risks in Cell and Gene Therapies

Stanford scientists used machine learning to design improved zinc fingers that target disease genes while minimizing immunogenicity risk .

Read the original at Genetic Engineering and Biotechnology News ↗

Mentions
Stanford
Tracked via
“AI Risks”

Related articles

  • AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds AI Use Cases · Sep 17, 2025
  • Assessing shared failures with AI is key to cell and gene therapy's evolution - BioSpace AI Risks · Aug 18, 2026
  • AI transforms cell & gene therapy manufacturing with real-time insights - CFOtech Asia AI Risks · Sep 24, 2025
  • Takeda drops AstraZeneca-partnered neurological program after phase 2 failure AI Risks · Oct 30, 2025
  • AI for crop yield, gene diversity, breast cancer, climate data, and Africa's health burden AI Risks · Jul 18, 2025
  • Waypoint Bio Raises $20M to Advance AI -Designed Cell Therapies With Clinical Trials in China AI Risks · Jun 03, 2026

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact